Making invasive tumours benign
CELEX
A FEW WORDS ABOUT US
CELEX Oncology focus on treating agressive, invasive and metastatic cancer forms.
CELEX is based on research conducted at Imperial College in United Kingdom by Professor M. Djamgoz and his group. Professor Djamgoz has identified the mechanisme in Breast and Colon cancer that turn these cancers forms from benign tumours into aggressive, invasive and metastatic tumours.
WHAT WE DO
INDICATIONS
We are targeting breast and colon cancer. 12,0 % of all women in the Nordic countries and 2,2% of all men are diagnosed with one of the deceases before the age of 75
TECHNOLOGY
The CELEX mechanism describes how a tumour transforms form being a benign tumour into an aggressive and invasive tumour.
EVIDENCE
Data shows that by blocking the central function of the mechanism the metastasis and evasiveness of the tumour can be stopped
CONTACT US
9th floor, the Royal Liver Building
Pier Head
Liverpool, L3 1 JH
United Kingdom
Tel: +45 21 14 12 39
© Copyright 2019. All Rights Reserved.